HIGHLIGHTS
- who: Berend J. Slotman from the Inc, Suite, , th Street, Denver, CO, USA have published the research work: Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia, in the Journal: (JOURNAL)
- what: In sharp contrast, the present analysis shows nearly 70% of prostate patients treated on 0.35T-MRgRT systems received their treatment by SBRT in 2020. Despite the large number of treatment courses , the current analysis has limitations. The source of the data was the 0.35T-MRgRT systems and was originally collected as part of the clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.